140 related articles for article (PubMed ID: 37838222)
1. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
3. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
4. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
5. Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling.
Yu Y; Wu T; Lu Y; Zhao W; Zhang J; Chen Q; Ge G; Hua Y; Chen K; Ullah I; Zhang F
Free Radic Biol Med; 2022 Nov; 193(Pt 1):108-121. PubMed ID: 36241072
[TBL] [Abstract][Full Text] [Related]
6. Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes.
Mao M; Zheng W; Deng B; Wang Y; Zhou D; Shen L; Niku W; Zhang N
PLoS One; 2023; 18(10):e0292124. PubMed ID: 37824478
[TBL] [Abstract][Full Text] [Related]
7. Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways.
Lu Z; Liu Z; Fang B
Bioengineered; 2022 Apr; 13(4):9145-9155. PubMed ID: 35363601
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis.
Li D; Song C; Zhang J; Zhao X
J Nutr Biochem; 2023 Feb; 112():109241. PubMed ID: 36442718
[TBL] [Abstract][Full Text] [Related]
9. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
13. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
14. Beta vulgaris-derived exosome-like nanovesicles alleviate chronic doxorubicin-induced cardiotoxicity by inhibiting ferroptosis.
Cai J; Pan J
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23540. PubMed ID: 37728183
[TBL] [Abstract][Full Text] [Related]
15. FGF12 restrains mitochondria-dependent ferroptosis in doxorubicin-induced cardiomyocytes through the activation of FGFR1/AMPK/NRF2 signaling.
Tian G; Li J; Wang W; Zhou L
Drug Dev Res; 2024 Feb; 85(1):e22149. PubMed ID: 38349269
[TBL] [Abstract][Full Text] [Related]
16. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.
Sun X; Sun P; Zhen D; Xu X; Yang L; Fu D; Wei C; Niu X; Tian J; Li H
Toxicol Appl Pharmacol; 2022 Feb; 437():115902. PubMed ID: 35093381
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
[TBL] [Abstract][Full Text] [Related]
18. Echinacoside ameliorates doxorubicin‑induced cardiac injury by regulating GPX4 inhibition‑induced ferroptosis.
Ma Y; Yang X; Jiang N; Lu C; Zhang J; Zhuang S
Exp Ther Med; 2024 Jan; 27(1):29. PubMed ID: 38125366
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation.
Zhang H; Pan J; Huang S; Chen X; Chang ACY; Wang C; Zhang J; Zhang H
Redox Biol; 2024 Apr; 70():103066. PubMed ID: 38359744
[TBL] [Abstract][Full Text] [Related]
20. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]